Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Study of Surgery in Combination With Neoadjuvant Chemotherapy of Oxaliplatin Plus Capecitabine in Colorectal Cancer With Respectable Liver Metastasis

NCT00630045 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT00630045
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00630045 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Study of Surgery in Combination With Neoadjuvant Chemotherapy of Oxaliplatin Plus Capecitabine in Colorectal Cancer With Respectable Liver Metastasis
Lead sponsor
Peking University People's Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
January 31, 2008
Completion date
June 30, 2015
Enrollment
392 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, resectable liver metastasis